855.846.6529 tmiles@timmileslaw.com

Shareholder Alerts

Our Most recent news, and featured press stories.

Investigation of Poseida Therapeutics, Inc. Call (855) 846-6529 or Email: tmiles@timmileslaw.com

The Law Offices of Timothy L. Miles Is Investigating the Officers and Directors of Poseida Therapeutics, Inc.  (PSTX) on Behalf of Shareholders Poseida conducted its IPO on July 10, 2020, issuing 14 million shares for $16.00 per share.  On August 18, 2020, Poseida announced that the U.S. Food and Drug Administration had placed a clinical hold on...

read more

Investigation of Qutoutiao Inc.

Call (855) 846-6529 or Email: tmiles@timmileslaw.com Qutuotiao Inc. (QTT) Accused of Misleading Shareholders  Qutuotiao held its IPO on September 14, 2018, offering 13.8 million shares at $7.00 per share for gross proceeds of approximately $85.8 million.  As noted in the Company’s IPO documents, a majority of the Company’s revenues...

read more

Investigation of OneSpan Inc.

OneSpan Shareholders Contact: Phone: (855) 846 6529; Email:tmiles@timmileslaw.com OneSpan Inc. (OSPN) Shocks Investors with Reporting Errors OneSpan Inc. made false and misleading statements regarding the Company’s internal policies and downplayed the likely negative impact on its profits.  On August 4, 2020, OneSpan postponed its...

read more

Investigation of Baidu, Inc.

Baidu, Inc. (BIDU) Accused of Misleading Shareholders   In 2015, Baidu, in its filings with the Securities and Exchange Commission (“SEC”), reported, “In November, we obtained a controlling interest in Qiyi.com, Inc., or iQiyi, a prior equity method investee, and have since consolidated its financial results into its consolidated financial...

read more

Investigation of GoHealth, Inc.

The Law Offices of Timothy L. Miles Is Investigating the Officers and Directors of GoHealth, Inc. (GOCO) on Behalf of Shareholders GoHealth conducted its IPO on July 15, 2020, selling approximately 43.5 million shares for $21.00 per share raising nearly $914 million.  On August 21, 2020, GoHealth reported its first quarterly earnings since its...

read more

Investigation of Vaxart, Inc.

Vaxart, Inc. (VXRT) Offers Spring-Loaded Stock Options to Officers and Director In early 2020 when Vaxart’s shares only traded around 35 cents, the Company began working on the development of a COVID-19 vaccine. As time progressed, the Company continuously touted positive improvement in its COVID-19 vaccine development efforts. Experiencing a...

read more

Investigation of Eastman Kodak Company

Kodak (KODK) Executives Receive Stock Option Grants Prior to Explosion in Stock Price On July 27, 2020, Kodak granted its CEO and Executive Chairman 1.75 million stock options, and 45,000 options each to its CFO, VP, and General Counsel.  That same day, Kodak issued a statement to media outlets based in Rochester, NY, regarding “a new...

read more

Investigation of MEI Pharma, Inc.

MEI Pharma, Inc. (MEIP) Accused of Misleading Shareholders    In 2016 MEI Pharma, Inc. (MEIP) entered into an exclusive license agreement with Helsinn Healthcare SA, a Swiss pharmaceutical corporation (“Helsinn”), in which Helsinn would develop, manufacture, and commercialize Pracinostat while MEI Pharma received $20 million for the...

read more

Investigation of Cheetah Mobile, Inc.

Cheetah Mobile Inc. (CMCM) Accused of Misleading Shareholders  Cheetah Mobile announced positive financial results for its fourth quarter and 2018 annual report. In the following months, Cheetah Mobile continued to issue optimistic financial outlooks. However, the Company failed to disclose that certain Cheetah Mobile apps were in violation...

read more

Let’s Work Together